Unknown NA INTERVENTIONAL 5-arm NCT05842278

The Dosage Effect of pBFS Guided rTMS Treatment for MDD

The Dosage Effect of Personalized Brain Functional Sectors(pBFS) Guided rTMS Treatment for Major Depressive Disorder： a Randomized， Double-Blind， Sham-controlled Trial

Sponsor: Beijing HuiLongGuan Hospital

Conditions Major Depressive Disorder Moderate Depression Severe Depression

Interventions 10 session rTMS 4 session rTMS 6 session rTMS 8 session rTMS sham rTMS

Updated 5 times since 2023 Last updated: Jul 12, 2023 Started: Jul 7, 2023 Primary completion: Jul 31, 2024 Completion: Oct 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Major Depressive Disorder and Moderate Depression and is currently ongoing. Beijing HuiLongGuan Hospital leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Aug 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Aug 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2023 — Aug 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing HuiLongGuan Hospital
Changping Laboratory

Data source: Changping Laboratory

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China